PRESS RELEASE GlobeNewswire Jun. 16, 2020, 08:44 AM Dublin, June 16, 2020 (GLOBE NEWSWIRE) -- The "Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to ...

Hydroxychloroquine May Tame Preeclampsia in Lupus Patients Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a Swedish cohort ...

About Enpatoran Enpatoran is a selective Toll-like receptor (TLR)7/8 inhibitor under investigation for the treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE).

Patients with both systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) showed a distinct clinical phenotype from those with SSc alone, but mortality was similar.

2. Dörner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet 2019;393:2344-2358.

Toni Braxton on living with lupus and spreading awareness about the disease May is Lupus Awareness Month and Toni Braxton is using the opportunity to speak out about living with this chronic ...

Patients who received an mRNA COVID-19 vaccine demonstrated a 1.16-fold higher long-term risk for systemic lupus erythematosus, while a booster was linked to higher risk for psoriasis and ...